|Videos|November 6, 2019
AMCP NEXUS 2019 Street Team: Jann R. Rigell of MedImpact Direct
Author(s)AMCP Nexus 2019 Street Team
Advertisement
At AMCP 2019, Jann R. Rigell, RPh, MBA, principal, Enterprise Specialty Programs, MedImpact Direct, shares strategies to rein in specialty drugs costs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Review calls for combining outcome measures for hidradenitis suppurativa treatment
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Transparency is out. Actionable data is in. | PBMI 2026
4
States push for new PBM reporting rules | PBMI 2026
5












